Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 49,902 | 22,921 | 73,946 | 51,686 | 32,347 |
| Depreciation Amortization | 11,783 | 5,422 | 18,933 | 13,933 | 9,212 |
| Income taxes - deferred | N/A | N/A | 7,567 | N/A | N/A |
| Other Working Capital | -36,542 | -7,614 | -7,737 | 2,785 | -3,558 |
| Loans | -3,079 | -1,158 | -574 | -169 | 0 |
| Other Operating Activity | 13,246 | 5,569 | 20,417 | 14,972 | 9,993 |
| Operating Cash Flow | $35,310 | $25,140 | $112,552 | $83,207 | $47,994 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,410 | -1,402 | 5,895 | 7,140 | -1,784 |
| Net Acquisitions | 92,419 | 92,419 | 82,403 | -5,983 | N/A |
| Purchase Of Investment | -47,195 | -21,952 | -60,165 | -44,416 | -40,300 |
| Sale Of Investment | 154,951 | 79,487 | 291,976 | 219,560 | 149,850 |
| Net Loans | -253,191 | -101,114 | -1,078,216 | -997,667 | -643,811 |
| Other Investing Activity | 122 | -1,573 | -338 | 604 | 351 |
| Investing Cash Flow | $-57,304 | $45,865 | $-758,445 | $-820,762 | $-535,694 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 151,549 | 103,379 | 46,863 | 141,936 | 46,365 |
| Debt Issued | 1,232,744 | 557,744 | 2,316,797 | 1,985,866 | 1,379,784 |
| Debt Repayment | -1,213,095 | -528,046 | -2,519,021 | -2,055,766 | -1,486,072 |
| Common Stock Issued | 3,070 | 2,401 | 8,369 | 4,774 | 3,340 |
| Dividend Paid | -7,246 | -3,153 | -8,895 | -6,670 | -4,023 |
| Other Financing Activity | -11,997 | 1,403 | -25,585 | -21,318 | 1,283 |
| Financing Cash Flow | $34,705 | $-32,896 | $693,151 | $749,860 | $472,167 |
| Beginning Cash Position | 178,565 | 178,565 | 131,307 | 131,307 | 131,307 |
| End Cash Position | 191,276 | 216,674 | 178,565 | 143,612 | 115,774 |
| Net Cash Flow | $12,711 | $38,109 | $47,258 | $12,305 | $-15,533 |
| Free Cash Flow | |||||
| Operating Cash Flow | 35,310 | 25,140 | 112,552 | 83,207 | 47,994 |
| Capital Expenditure | -7,202 | -2,990 | -15,120 | -11,742 | -7,486 |
| Free Cash Flow | 28,108 | 22,150 | 97,432 | 71,465 | 40,508 |